FDA Grants Anixa Biosciences' Individual Patient IND for Second Dose of CAR-T Ovarian Cancer Therapy
Jul 23, 2024
Car-t Invest Information
FDA Greenlights Immix Biopharma's IND for CAR-T Therapy NXC-201, Paving the Way for US Clinical Trials
Nov 21, 2023